Liver medicine is at a turning point. To deliver cutting-edge patient care and lead the field, healthcare professionals need a definitive guide to the clinical discoveries reshaping hepatology.
The latest issue of EMJ Hepatology is now live, distilling high-impact insights spanning viral hepatitis, liver cancer, cirrhosis, and transplantation into a concise, actionable format.
Driving the Future of Liver Care
We cut through the noise to bring you the evidence-based research shifting clinical practice today:
- Functional Cure in Sight: How immunology and vaccine advances are pushing chronic hepatitis B seroconversion to 56%.
- New EASL Guidelines: Rewriting the rules of care, moving from “wait and see” to “test and treat.”
- The Cost of Easing Off: New evidence reveals how returning disease post-transplant collapses 5-year survival from 92% to 33%.
Expert Analysis, Fully Accessible
Featuring exclusive coverage and 6 unmissable clinical articles, this issue is backed by over 100 world-class contributors. We believe the advancements shaping the future of liver medicine should be fully open-access for every practitioner driving the field forward.
This is the knowledge your peers are already reading. It’s free, it’s vital, and it’s available now.
